BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11846040)

  • 1. Adult-onset xeroderma pigmentosum neurological disease--observations in an autopsy case.
    Robbins JH; Kraemer KH; Merchant SN; Brumback RA
    Clin Neuropathol; 2002; 21(1):18-23. PubMed ID: 11846040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of the inner ear in patients with xeroderma pigmentosum and neurologic degeneration.
    Viana LM; Seyyedi M; Brewer CC; Zalewski C; DiGiovanna JJ; Tamura D; Totonchy M; Kraemer KH; Nadol JB
    Otol Neurotol; 2013 Sep; 34(7):1230-6. PubMed ID: 23928520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies.
    Lehky TJ; Sackstein P; Tamura D; Quezado M; Wu T; Khan SG; Patronas NJ; Wiggs E; Brewer CC; DiGiovanna JJ; Kraemer KH
    BMC Neurol; 2021 Oct; 21(1):393. PubMed ID: 34627174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form.
    Robbins JH; Brumback RA; Mendiones M; Barrett SF; Carl JR; Cho S; Denckla MB; Ganges MB; Gerber LH; Guthrie RA
    Brain; 1991 Jun; 114 ( Pt 3)():1335-61. PubMed ID: 2065254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cockayne syndrome and xeroderma pigmentosum.
    Rapin I; Lindenbaum Y; Dickson DW; Kraemer KH; Robbins JH
    Neurology; 2000 Nov; 55(10):1442-9. PubMed ID: 11185579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).
    Lai JP; Liu YC; Alimchandani M; Liu Q; Aung PP; Matsuda K; Lee CC; Tsokos M; Hewitt S; Rushing EJ; Tamura D; Levens DL; Digiovanna JJ; Fine HA; Patronas N; Khan SG; Kleiner DE; Oberholtzer JC; Quezado MM; Kraemer KH
    Acta Neuropathol Commun; 2013 May; 1():4. PubMed ID: 24252196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically asymptomatic xeroderma pigmentosum neurological disease in an adult: evidence for a neurodegeneration in later life caused by defective DNA repair.
    Robbins JH; Brumback RA; Moshell AN
    Eur Neurol; 1993; 33(3):188-90. PubMed ID: 8467834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to UV radiation of fibroblasts from a Japanese group A xeroderma pigmentosum patient with mild neurological abnormalities.
    Sato K; Watatani M; Ikenaga M; Kozuka T; Kitano Y; Yoshikawa K; Mimaki T; Abe J; Sugita T
    Br J Dermatol; 1987 Jan; 116(1):101-8. PubMed ID: 3814505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum.
    Robbins JH; Polinsky RJ; Moshell AN
    Ann Neurol; 1983 Jun; 13(6):682-4. PubMed ID: 6881931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.
    Andrews AD; Barrett SF; Robbins JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1984-8. PubMed ID: 273925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed Audiological Evaluation of a Patient with Xeroderma Pigmentosum with Neural Degeneration.
    Mercer D; Hurley A; Tsien F
    J Am Acad Audiol; 2017 Jan; 28(1):80-90. PubMed ID: 28054914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
    Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
    Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum with neurological abnormalities. A clinical and neuropathological study.
    Röyttä M; Anttinen A
    Acta Neurol Scand; 1986 Feb; 73(2):191-9. PubMed ID: 3705928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurological abnormalities in xeroderma pigmentosum].
    El Fékih N; Fredj M; Aounallah-Skhiri H; Fazaa B; Zghal M; Ridha Kamoun M
    Rev Neurol (Paris); 2009 Nov; 165(11):967-70. PubMed ID: 19268336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum: recent clinical and photobiological aspects.
    Kondo S; Fukuro S; Nishioka K; Satoh Y
    J Dermatol; 1992 Nov; 19(11):690-5. PubMed ID: 1293156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Xeroderma pigmentosum].
    Takeuchi S
    Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum: beyond skin cancer.
    Lichon V; Khachemoune A
    J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
    Brooks PJ
    Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of xeroderma pigmentosum complementation group F with neurological abnormalities.
    Moriwaki S; Nishigori C; Imamura S; Yagi T; Takahashi C; Fujimoto N; Takebe H
    Br J Dermatol; 1993 Jan; 128(1):91-4. PubMed ID: 8427828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on 'xeroderma pigmentosum'.
    Fassihi H
    Photochem Photobiol Sci; 2013 Jan; 12(1):78-84. PubMed ID: 23132518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.